Zoek binnen de website

home / news & insights /

Amsterdam, 20 februari 2024

Lindenbaum is proud to sponsor the IBA Annual Litigation Forum

By Damiën Berkhout & Guido Vergouwen

The International Bar Association will be hosting their three-day Annual Litigation Forum in Amsterdam from 17 to 19 April 2024. This year the Forum will revolve around key litigation themes such as The Hague Convention, cross-border enforcement, the handling of expert witnesses, and trends in class actions.

Lindenbaum will be sponsoring the conference diner, and our partners Guido Vergouwen and Damiën Berkhout will be delegates at the Forum. We hope that our friends and colleagues from The Netherlands and elsewhere will find the time to join us in Amsterdam, during the Forum and the dinner.

About the IBA

The IBA is the leading organization for international legal practitioners, bar associations and law societies. Established in 1947, shortly after the creation of the United Nations, with the aim of protecting and advancing the rule of law globally, the IBA was born out of the conviction that an organization made up of the world’s bar associations could contribute to global stability and peace through the administration of justice. The present membership is comprised of more than 80,000 individual international lawyers from most of the world’s leading law firms and some 190 bar associations and law societies spanning more than 170 countries. For more information about the IBA: https://www.ibanet.org/About-the-IBA

About Lindenbaum

Lindenbaum is a dispute resolution law firm. The firm specializes in commercial litigation, antitrust litigation, corporate litigation and class actions. We look for amicable solutions where possible, and vigorously pursue our clients’ claims in court when litigation is the best option. For more information about Lindenbaum: https://www.lindenbaum.nl/about-the-firm/

Damiën Berkhout

Partner, dispute resolution expert

Contact

Guido Vergouwen

Partner, corporate litigation expert

Contact

Meer publicaties

Collective action on excessive pricing of pharmaceuticals moves on to merits phase

5 september 2024 - News

The Amsterdam District Court ruled that the representative organization Stichting Farma Ter Verantwoording is admissible in its collective action against pharmaceutical giant AbbVie. The case now moves on to the merits phase, in which the court will assess whether Abbvie abused its dominant position and violated human rights by charging excessive prices for its Humira medicine.

Lees meer

Amsterdam Court of Appeal provides key decision regarding WAMCA admissibility requirements

28 augustus 2024 - Insights

The Amsterdam Court of Appeal has provided guidance for future Dutch mass tort cases in its decision in the matter between The Privacy Collective and Oracle and Salesforce.

Lees meer

Recente ontwikkelingen vernietiging bij aandelenkoop

12 augustus 2024 - Publications

Lindenbaum-partner Guido Vergouwen heeft een annotatie geschreven voor de JIN over problemen bij vernietiging van een aandelenkoop naar aanleiding van het Hoge Raad-arrest Rookie/ABC Hekwerk c.s.

Lees meer